Clinical Trials Directory

Trials / Completed

CompletedNCT00859196

Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries

A Randomized, Double-blind, Single Centre, Placebo-controlled Pilot Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Previously Injured Skin by Investigation of Skin Biopsies

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Bayer · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

In previous in vitro studies it could be shown, that Dexpanthenol has an influence on the gene expression of fibroblasts. The genes which are influenced by Dexpanthenol play mainly a role during cell proliferating processes.The aim of this study is to investigate the molecular effect of Dexpanthenol on human living skin, during wound healing.

Conditions

Interventions

TypeNameDescription
DRUGDexpanthenol (BAY81-2996)Test product and the respective placebo will be applied to previously wounded test areas and the surrounding skin (approx. 3 cm2). After a certain time the second skin biopsy will be taken from the treated test areas. The skin biopsies will be analysed via micro array.
DRUGPlaceboTest product and the respective placebo will be applied to previously wounded test areas and the surrounding skin (approx. 3 cm2). After a certain time the second skin biopsy will be taken from the treated test areas. The skin biopsies will be analysed via micro array.

Timeline

Start date
2009-02-01
Primary completion
2009-02-01
Completion
2009-03-01
First posted
2009-03-10
Last updated
2014-12-09

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00859196. Inclusion in this directory is not an endorsement.